The cell and gene therapy market is at a pivotal point, with a surge in approvals and a maturing pipeline. While oncology ...
Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback